Get Email Alerts
Font Size
The National Heart, Lung, and Blood Institute (NHLBI), along with federal and non-federal partners, today released the first-ever COPD National Action Plan, a detailed, patient-centered roadmap for addressing one of the most urgent health concerns facing Americans. The plan was released at the American Thoracic Society International Conference meeting this week in Washington, D.C. NHLBI is part of the National Institutes of Health.
Living in racially segregated neighborhoods is associated with a rise in the blood pressure of black adults, while moving away from segregated areas is associated with a decrease —and significant enough to lead to reductions in heart attacks and strokes, a National Institutes of Health-funded study has found.
The COPD National Action Plan, released at the American Thoracic Society International Conference meeting this week in Washington, D.C., is a detailed, patient-centered roadmap that aims to reduce the burden of the third leading cause of death.
MedicalXpress: New COPD action plan outlines strategies for improved care
EurekAlert!: ATS 2017: New COPD action plan outlines strategies for improved care
Mast cells, a type of white blood cell, are present in the airways of severe asthmatics even in the face of aggressive treatment. In a new, proof-of-principle study published in the New England Journal of Medicine, NHLBI-funded researchers found that targeting the mast cells with imatinib, a drug used in cancer treatments, improved airway hyperresponsiveness, a measure of the sensitivity of the airway, and decreased the number of mast cells present in the airway.
STAT: Blockbuster cancer drug shows surprising promise in treating severe asthma
Pharmacy Times: Could This Cancer Drug Benefit Patients with Severe Asthma?
Drug Discovery and Development: Study Finds Imatinib Improves Symptoms for Patients with Severe Asthma
Medical Xpress: Proof-of principle study finds imatinib improves symptoms for patients with severe asthma
Washington University School of Medicine: Cancer drug may help patients with severe asthma
